ÂÜÀòÂÒÂ×

Amy Medeiros possesses extensive expertise in downstream process development within the biopharmaceutical sector, currently serving as Associate Director at Ultragenyx since November 2017, following progressive roles as Senior Scientist and Scientist II in the Gene Therapy Pilot Plant. Prior experience includes significant roles at Dimension Therapeutics and Momenta Pharmaceuticals, contributing to downstream process development as both a Senior Research Associate and Scientist I. Amy's foundational experience also encompasses research associate positions at Virdante Pharmaceuticals and EMD Serono, as well as earlier co-op positions in protein purification, cell culture, and sequencing. Educational qualifications include a Master of Science in Biotechnology: Process Development and a Bachelor's degree in Biology, both from Northeastern University.